Drug Deliver
Home Up Polyalkenoate Cytocompatibility Cytocompatibility 2 Knee prostheses Biodegrad. scaffold Bio-scaffold Drug Deliver Drug release Carcinogenicity Carcinogenicity 2 Ionomer glasses Anti-bacterial Anti-bacterial 2 UHMWPE UHMWPE 2 Knee implants Ceramics CERCODIM Perfluorocarbons Spinal spacer Ionomer Stability of materials IsoBone Hair follicle Membranes Orthopaedic Fixation Systems


Molecular and nano-scale drug-delivery systems 'MODELS'
Contract number
BRPR-CT97-0401 Proposal number
BE96-3621
Start date
01-May-97 Duration
3 years 6 months
RTD programme
Brite-EuRam
Budget ECU
0
Coordinator
Professor C Kiparissides

Organisation
Aristotle University of Thessaloniki
Department of Chemical Engineering
City University
Street
P.O. Box 472
City
Thessaloniki
Country
Greece Postcode
GR-540 06
Telephone
30 31 996212 / 996211 Fax
30 31 996198
Email
cypress@filippos.techpath.gr or cypress@alexandros.cperi.forth.gr
Web_address
n/a
Partner
University of London, UK
Partner
Albert-Ludwigs Unversitat, DE
Partner
NCSR Demokritos, GR
Partner
Asta Medica, DE
Partner
Lavipharm SA, GR
Summary
The present programme aims at the development of novel molecular / nano-scale controlled drug delivery systems based on liposomes, dendrimers, lipid/polymer nanoaggregates, nano- and microspheres , in which biologically active compounds will be incorporated, in order to find application in the biomedical and pharmaceutical industries.
Achievements

Updated April 1999


  • Preparation of liposome formulations incorporating the candidate drugs with/without the presence of a light absorber or/and antioxidant. Complexation of drugs with cyclodextrins. Upscalled liposome production.
  • Development of a new strategy of releasing active compounds into target cells by using transiently induced destabilization of cellular membranes by lipid / polymer nanoaggregates.
  • Incoproration of the candidate drugs within the molecular cavities of commercial or functionalized dendrimers.
  • Development of efficient encapsulation processes and detailed description of process operating conditions for the production of five different types of micro- and nanospheres and microgels containing the candidate drugs. Novel synthesis of composite microparticles with improved efficiency and stability characteristics.
  • In-vitro drug delivery studies from liposomes, microparticles and microgels. Product evaluation studies.

Previous Next Last

Back Up Next


All text and representations on this site © L P M Lloyd-Evans & BioBridge 2000-2005
mlloydevans@biobridge.co.uk.
Designed and managed by BioPortfolio Ltd on behalf of  L P M Lloyd-Evans & BioBridge Associates.

The foundation and maintenance of this site was made possible by EC funding in project BRRT-CT97-5008 1997-2000